Header Logo

Kimberly Lenz

Concepts (82)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
362
0.680
 Why?
Analgesics, Opioid
4
2019
534
0.570
 Why?
Pain
3
2019
404
0.570
 Why?
Medication Therapy Management
3
2018
21
0.390
 Why?
Antiviral Agents
3
2018
322
0.330
 Why?
Practice Patterns, Physicians'
5
2019
713
0.310
 Why?
Hepatitis C
2
2016
151
0.220
 Why?
United States
10
2019
7824
0.170
 Why?
Drug Utilization Review
2
2017
52
0.160
 Why?
Chloride Channel Agonists
1
2019
3
0.160
 Why?
Aminophenols
1
2019
4
0.160
 Why?
Drug and Narcotic Control
2
2017
28
0.160
 Why?
Benzodioxoles
1
2019
13
0.160
 Why?
Aminopyridines
1
2019
32
0.160
 Why?
Quinolones
1
2019
29
0.160
 Why?
Uridine Monophosphate
1
2018
9
0.150
 Why?
Fluorenes
1
2018
14
0.150
 Why?
Cystic Fibrosis
1
2019
121
0.150
 Why?
Benzimidazoles
1
2018
54
0.140
 Why?
Psychotropic Drugs
1
2018
81
0.140
 Why?
Insurance, Pharmaceutical Services
2
2014
19
0.140
 Why?
Hydrocodone
1
2017
7
0.140
 Why?
Hepatitis C, Chronic
1
2018
88
0.140
 Why?
Drug Prescriptions
1
2018
167
0.130
 Why?
Opioid-Related Disorders
2
2014
497
0.130
 Why?
Hepacivirus
1
2018
141
0.130
 Why?
Progesterone
1
2017
163
0.130
 Why?
Premature Birth
1
2017
112
0.120
 Why?
Medication Adherence
1
2017
202
0.120
 Why?
Prescription Drug Diversion
1
2014
7
0.110
 Why?
Lung
1
2019
952
0.110
 Why?
Prescription Drug Misuse
1
2014
20
0.110
 Why?
State Government
1
2014
32
0.110
 Why?
Drug Combinations
3
2019
165
0.110
 Why?
Drug Interactions
1
2014
127
0.110
 Why?
Managed Care Programs
1
2014
89
0.110
 Why?
Retrospective Studies
7
2018
6595
0.100
 Why?
Health Services Accessibility
1
2016
563
0.090
 Why?
Mental Disorders
1
2018
788
0.090
 Why?
Treatment Outcome
3
2016
5625
0.080
 Why?
Young Adult
4
2019
4673
0.070
 Why?
Adolescent
4
2019
6229
0.070
 Why?
Adult
6
2019
16736
0.060
 Why?
Humans
10
2019
63149
0.060
 Why?
Cost Savings
2
2016
54
0.060
 Why?
Drug Costs
2
2016
56
0.060
 Why?
Cost-Benefit Analysis
2
2017
310
0.060
 Why?
Female
7
2019
32709
0.060
 Why?
Program Evaluation
2
2018
488
0.050
 Why?
Middle Aged
5
2019
17480
0.050
 Why?
Pharmacists
2
2016
126
0.050
 Why?
Male
6
2019
29717
0.050
 Why?
Massachusetts
2
2018
2073
0.050
 Why?
Cohort Studies
2
2017
2560
0.040
 Why?
Child
2
2019
4520
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
76
0.040
 Why?
Sustained Virologic Response
1
2018
10
0.040
 Why?
Sofosbuvir
1
2018
17
0.040
 Why?
Ribavirin
1
2018
23
0.040
 Why?
Polypharmacy
1
2018
61
0.040
 Why?
Treatment Failure
1
2018
199
0.040
 Why?
Hydroxyprogesterones
1
2017
6
0.040
 Why?
Controlled Substances
1
2017
5
0.030
 Why?
Viral Load
1
2018
231
0.030
 Why?
Drug Therapy, Combination
1
2018
463
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
860
0.030
 Why?
Gestational Age
1
2017
189
0.030
 Why?
RNA, Viral
1
2018
276
0.030
 Why?
Psychiatry
1
2018
126
0.030
 Why?
Genotype
1
2018
664
0.030
 Why?
Insurance Claim Review
1
2016
76
0.030
 Why?
Evidence-Based Medicine
1
2018
460
0.030
 Why?
Pregnancy Outcome
1
2017
193
0.030
 Why?
Government Regulation
1
2014
41
0.030
 Why?
Interdisciplinary Communication
1
2014
105
0.030
 Why?
Physician's Role
1
2014
124
0.020
 Why?
Cooperative Behavior
1
2014
222
0.020
 Why?
Health Policy
1
2014
192
0.020
 Why?
Mutation
1
2019
2604
0.020
 Why?
Pregnancy
1
2017
2328
0.020
 Why?
Time Factors
1
2014
3754
0.020
 Why?
Aged
1
2018
14333
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_